Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes.

Haematologica - 1 Feb 2013

Gonzalez David, Else Monica, Wren Dorte, Usai Monica, Buhl Anne Mette, Parker Anton, Oscier David, Morgan Gareth, Catovsky Daniel

Abstract excerpt

CLLU1, located at chromosome 12q22, encodes a transcript specific to chronic lymphocytic leukemia and has potential prognostic value. We assessed the value of CLLU1 expression in the LRF CLL4 randomized trial. Samples from 515 patients with chronic lymphocytic leukemia were collected immediately...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gene Expression
Share to Immunoglobulin Heavy Chains
Share to Immunoglobulin Variable Region

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Neoplasm Proteins

Share to Prognosis

Share to RNA, Long Noncoding

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 22899580
DOI: 10.3324/haematol.2012.070201
PMCID: PMC3561436

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22899580-2026-09-04.1. Manifest publication-graph-cohort-2026-09-04.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes.PMID 22899580Read ↗

CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemiaSemantic proximity Read ↗

LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia.Semantic proximity Read ↗

Identification of a gene on chromosome 12q22 uniquely overexpressed in chronic lymphocytic leukemia.Semantic proximity Read ↗

COBLL1, LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational status.Semantic proximity Read ↗

Molecular pathogenesis of chronic lymphocytic leukemia.Semantic proximity Read ↗

Analysis of chronic lymphotic leukemia transcriptomic profile: differences between molecular subgroups.Semantic proximity Read ↗

Chronic lymphocytic leukemia: biology, disease progression, and current treatment strategies.Semantic proximity Read ↗

LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients.Semantic proximity Read ↗

Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI.Semantic proximity Read ↗

Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patients.Semantic proximity Read ↗

Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?Semantic proximity Read ↗

MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.